Day-1 | Session-1: Re-thinking the drivers of AMR emergence and spread
Professor David Aanensen from the Big Data Institute (BDI) of Oxford University moderated the session, which featured the Keynote Address by Professor Peter Collignon from Australian National University. The presentation was followed by a 20-minute Q&A with Prof. Collignon, moderated by Prof. Aanensen, and with questions from workshop participants.
Prof.Peter Collignon’s presentation slides are available here
Day-1 | Session-2: One Health ‘Integrated Analysis’: Challenges and Options for LMICs
Dr Olafur Valsson from the World Organisation for Animal Health (OIE) moderated the second session, featuring a presentation by Dr Gerard Moulin from ANSES in France on exemplars of One Health integrated analysis. The session was again followed by a 20-minute Q&A with questions from participants to Dr Moulin, moderated by Dr Valsson.
Dr.Gerard Moulin’s presentation slides are available here
Day-1 | Session-3: Brief Informational Sessions on TISSA and QWARS
The final session of Day 1 was hosted by Dr Holy Akwar from IVI’s RADAAR project, featuring brief informational sessions of data systems: the Tripartite Integrated System for Surveillance on AMR/AMU (TISSA) by Dr Arno Muller of WHO; and Qualifying the Workforce for AMR Surveillance in Africa and Asia (QWARS) by Anafi Mataka of ASLM. Q&As with both presenters were led by Dr Akwar.
Day-2 | Session-1: Panel Discussion:
Policy Implications and Recommendations from the GRAM, CAPTURA, and MAAP Projects
The first session of Day 2 was moderated by Professor Sabiha Essack of KwaZulu-Natal University (and Co-Chair WHO STAG-AMR) and focused on policy implications and recommendations from AMR-related projects. Dr Catrin Moore from St George’s, University of London, presented ‘Findings from the Global Research on Antimicrobial Resistance (GRAM)’ project. Dr Marianne Holm from IVI presented on ‘Findings from the Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA)’ project. Edwin Shumba from ASLM presented ‘Findings from the Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP)’ project. The presentations were followed by a Plenary/Q&A session moderated by Prof. Essack.
Day-2 | Session-2: Reflections:
Mobilizing Domestic Resources for AMR Interventions
Session 2 was moderated by Tom Pilcher of the Fleming Fund, DHSC, in the United Kingdom, reflecting on perspectives and experiences of resource mobilization. Dr Nithima Sumpradit from the MOPH in Thailand provided a country perspective. Dr Mirfin Mpundu of ReAct Africa, gave the international independent network perspective. Dr Yewande Alimi from the African Union/CDC described a regional perspective. Patrick Mubangizi of Mott Macdonald (E&S Africa Region) provided a Fund Manager perspective. A Plenary/Q&As moderated by Tom Pilcher provided participants with the opportunity to further explore the different perspectives.
Day-3 | Session-1: More than Just About Money:
A Journey from Patient to Policymaker
The first session of the final day was moderated by Dr Katinka de Balogh from FAO-HQ, with a presentation from Dr Nichola Naylor of the London School of Hygiene and Tropical Medicine (LSHTM) on ‘Economic concepts and analyses to support effective AMR policymaking’. The session was followed by a Plenary/Q&A moderated by Dr de Balogh.
Dr.Nichola Naylor’s presentation slides are available here
Day-3 | Session-2:
Strengthening Country Capacities to Translate AMR Data and Evidence into Effective Policies
The final session of the workshop was introduced by Satyajit Sarkar of IVI, who presented/‘soft-launched’ the RADAAR (IVI) and EVIPNet (WHO) collaborative initiative. Mr Sarkar introduced Tanja Kuchenmüller from WHO EVIPNet and the team – Professor Fadi El-Jardali from the American University in Beirut, and Dr Polonca Truden Dobrin and Dr Maja Šubelj from the National Institute of Public Health Slovenia – who gave an introduction to the EVIPNet approach, methodology, and country engagement activities, for strengthening country capacities for translating AMR evidence-to-policy.
EVIPNet Session Poll Results
Are countries able to systematically analyze and translate emerging AMR/U/C data and evidence to effectively inform or influence policy?
Is there a dedicated or ad hoc team at the national level specifically tasked with analyzing and translating AMR/U/C data and evidence into policy briefs for decision-makers?
How would you rate the current capacities in LMICs to translate AMR data/evidence to effective policy briefs and pitches to policymakers?
Do you think LMICs would benefit significantly from participating in a capacity strengthening initiative for translating AMR/U/C data and evidence into effective policies?
Is there any demand from policy and decision-makers for evidence-informed policy briefs to
weigh options for making effective policy choices?
EVIPNet Session Poll Results
How helpful were today’s workshop sessions in acquiring improved
understanding of policy options for AMR containment?
Based on your experience of today’s workshop sessions, would you attend
similar workshops/webinars organized by the RADAAR team in the future?